Mirati Therapeutics Receives Untitled Letter from OPDP for Overstating Cancer Drug Efficacy Read more
Pioneering Discussions at IISLD 2024: Advancing Treatment for PBC and Alpha-1 Antitrypsin Deficiency Read more
Congressional Budget Office Releases: Alternative Approaches to Reducing Prescription Drug Prices Read more